RESUMEN
Ectomesenchymal chondromyxoid tumor (ECT) is a rare soft tissue tumor with peculiar histogenesis, exhibiting a predilection for the dorsum of the tongue. Molecular evidence suggests that it may originate from the migration of ectomesenchymal pluripotent cells from the neural crest to the tongue, where these cells may eventually proliferate and undergo myxoid and chondroid differentiation. This article illustrates a case of a 16-year-old female patient who presented with a nodule on the dorsum of her tongue, which had been present for four years. Surgical excision was performed, and histopathological analysis revealed a myxoid neoplasia composed of polygonal and spindle cells within a loose stroma containing chondroid areas. Tumor cells were positive for GFAP and S-100 proteins on immunohistochemical study, confirming the diagnosis of ECT. After a 5-year follow-up, the patient has shown no evidence of recurrence. Although rare, ECT can be diagnosed straightforwardly due to its distinctive clinical, histopathological, and immunohistochemical features. Clinicians and pathologists should become familiar with this tumor in order to avoid misdiagnosis.
Asunto(s)
Neoplasias de la Lengua , Humanos , Femenino , Neoplasias de la Lengua/patología , Adolescente , Mesenquimoma/patología , Mesenquimoma/diagnóstico , Biomarcadores de Tumor/análisisRESUMEN
BACKGROUND Phosphaturic mesenchymal tumor (PMT) is an extremely rare mesenchymal neoplasm that is commonly seen in bone and soft tissue. It is associated with a paraneoplastic syndrome, oncogenic osteomalacia, due to tumor-induced urinary phosphate wasting. It is demonstrated to be predominantly mediated by fibroblast growth factor 23 (FGF23)/fibroblast growth factor receptor 1 (FGFR1) axis. Clinically, PMT usually presents as a solitary lesion in the bone. The diagnosis of PMT is challenging due to its non-specific clinical manifestation, radiologic findings, and morphological features. CASE REPORT We report the case of a 50-year-old man presenting with multiple lytic bone lesions and associated pathologic fracture of the right femur, clinically suspicious for multiple myeloma or other metastatic malignant process. Resection from the right femur showed a hypercellular lesion composed of oval-to-spindled cells infiltrating the native trabecular bone with admixed multinucleated giant cells. Immunohistochemical (IHC) staining and in situ hybridization (ISH) demonstrated the tumor cells were positive for SATB2, ERG, FGFR1, and FGF23 ISH. DNA and RNA next-generation sequencing showed marked increases in mRNA levels of FGF23 and FGFR1. The constellation of clinicoradiologic, histomorphologic, IHC, and molecular findings supported a diagnosis of primary benign PMT. CONCLUSIONS This case report discusses a patient with PMT presenting with multifocal lesions due to tumor-induced osteomalacia at initial presentation. We hope that this report will increase the awareness of clinician and pathologists of PMT as a differential diagnosis in patients presenting with multifocal lytic bone lesions. In turn, this will prevent misdiagnosis and overtreatment of a typically benign process.
Asunto(s)
Mesenquimoma , Neoplasias de Tejido Conjuntivo , Osteomalacia , Síndromes Paraneoplásicos , Neoplasias de los Tejidos Blandos , Masculino , Humanos , Persona de Mediana Edad , Neoplasias de Tejido Conjuntivo/etiología , Neoplasias de Tejido Conjuntivo/genética , Neoplasias de los Tejidos Blandos/patología , Mesenquimoma/diagnóstico , Mesenquimoma/genética , Mesenquimoma/patología , Extremidad Inferior/patología , Fémur , Síndromes Paraneoplásicos/diagnóstico , Síndromes Paraneoplásicos/etiologíaRESUMEN
BACKGROUND: Spinal phosphaturic mesenchymal tumor (PMT) is a rare disorder but can be cured once the diagnosis is clear and a complete removal by surgery is performed. To the best of our knowledge, only 22 cases in the spine have been described, and we report a case with the largest number of spinal segments (T12-L5) affected among spine PMT cases. METHODS: A comprehensive literature search was performed until May 23, 2023, following the Preferred Reporting Items for Systematic Reviews guidelines. Studies were chosen through relevant PubMed, Web of Science, and EMBASE searches to prioritize obtaining the largest studies. The Medical Subject Headings and Boolean operators employed for this search were ("PMT" or "TIO" or "Tumor-induced osteomalacia" or "phosphaturic mesenchymal tumor") and ("spine" or "spinal"). Two researchers (L.S.Z. and D.B.C) independently reviewed and evaluated the included articles. Any differing opinions were discussed until a consensus was reached. A total of 18 studies were included. A case report is also presented. RESULTS: We report a case of spinal PMT. The full text of the relevant articles was construed. A total of 18 studies were reviewed and consolidated. These articles are roughly divided into the following 5 subcategories: 1) clinical features and baseline distribution, 2) laboratory and imaging findings, 3) pathological manifestations, and 4) surgical methods and treatment options. CONCLUSIONS: Spinal PMT is very rare with a high rate of misdiagnosis and debilitating complications, so it is of significance to increase awareness of the disease among spine surgeons consulted by patients with spinal PMT. 68Ga-DOTATOC-PET/CT shows very high sensitivity to the spinal PMT but there is no way to exactly determine the location of the tumor. PMT has unique immunohistochemical characteristics and malignant PMT is rare. Once diagnosed, complete surgical excision is the recommended treatment. Burosumab is one of the available options, especially in cases that are recurrent and difficult to surgically resect.
Asunto(s)
Osteomalacia , Neoplasias de la Columna Vertebral , Humanos , Neoplasias de la Columna Vertebral/cirugía , Neoplasias de la Columna Vertebral/diagnóstico por imagen , Neoplasias de la Columna Vertebral/complicaciones , Osteomalacia/etiología , Síndromes Paraneoplásicos , Neoplasias de Tejido Conjuntivo/cirugía , Neoplasias de Tejido Conjuntivo/diagnóstico por imagen , Femenino , Mesenquimoma/cirugía , Mesenquimoma/complicaciones , Mesenquimoma/diagnóstico , Mesenquimoma/diagnóstico por imagen , Mesenquimoma/patología , MasculinoRESUMEN
Tumor-induced osteomalacia (TIO) is a disorder in which the clinical signs and symptoms of osteomalacia and the biochemical abnormalities of hypophosphatemia, phosphaturia, and low serum levels of 1,25(OH)2 Vitamin D3 are secondary to a neoplasm. A 33-year-old woman presented with musculoskeletal pain and proximal myopathy with a duration of 2.5 years which was treated with Vitamin D supplements. On the basis of the biochemical tests and histopathology, she was reevaluated and found to have TIO secondary to a phosphaturic mesenchymal tumor. The tumor was resected (limb salvage with endoprosthesis), and she had no pain or weakness at followup. The case reminds the readers to consider the possibility of TIO when evaluating patients with isolated hypophosphatemia, which may lead to long-term disability and prolonged morbidity if untreated. Early recognition and diagnosis of TIO is crucial since resection of the tumor usually reverses its manifestations.
Asunto(s)
Hipofosfatemia , Enfermedades Musculares , Osteomalacia , Síndromes Paraneoplásicos , Humanos , Femenino , Adulto , Osteomalacia/etiología , Síndromes Paraneoplásicos/etiología , Síndromes Paraneoplásicos/diagnóstico , Hipofosfatemia/etiología , Enfermedades Musculares/etiología , Enfermedades Musculares/diagnóstico , Mesenquimoma/complicaciones , Mesenquimoma/cirugía , Mesenquimoma/patología , Mesenquimoma/diagnóstico , Resultado del Tratamiento , Recuperación del Miembro , Biopsia , Neoplasias de Tejido Conjuntivo/cirugía , Neoplasias de Tejido Conjuntivo/etiologíaRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adulto , Tumores del Estroma Gastrointestinal/diagnóstico , Mesenquimoma/diagnóstico , Predisposición Genética a la EnfermedadRESUMEN
El sarcoma sinovial representa el cuarto tipo de sarcoma más frecuente, situándose principalmente en las articulaciones de la rodilla y el tobillo, siendo excepcional la afectación de cabeza y cuello. Se da sobre todo en varones entre los 20 y 40 años. El diagnóstico suele ser inesperado por la rareza de la entidad y por las características inespecíficas clínico-radiológicas, basándose, por tanto, en técnicas inmunohistoquímicas y de microscopia electrónica. Presentamos un caso de sarcoma sinovial bifásico, localizado en la fosa infratemporal, tratado en nuestro servicio, y revisamos la literatura (AU)
Synovial sarcoma is the fourth most common type of sarcoma. It is usually found in the knee or ankle joints, and is exceptional in the head and neck. Most cases are diagnosed in men between 20 and 40 years of age. Diagnosis is often casual due to the infrequent nature of this tumour and its non-specific clinical and radiological characteristics. Confirmation is therefore based on immunohistochemistry and electron microscopy techniques. We report a case of biphasic sinovial sarcoma located in the infratemporal fossa treated at our hospital and we make a review of the literature (AU)
Asunto(s)
Humanos , Femenino , Anciano , Sarcoma Sinovial/diagnóstico , Neoplasias Infratentoriales/diagnóstico , Mesenquimoma/diagnóstico , Neoplasias de Cabeza y Cuello/diagnósticoRESUMEN
Se evaluaron las historias médicas con diagnóstico de tumores mesenquimales confirmados por análisis inmunohistoquímico entre los años 2007 y 2009. El objetivo fue describir a la población según características clínicas, epidemiológicas, diagnósticos por imágenes y análisis anatomopatológico. Se obtuvieron 11 pacientes con diagnósticos de GIST(7), Leiomiomas(2), GANT(1) y Leiomiosarcoma(1). Del género femenino (82%) y masculino (18%). Con un promedio de 55 años de edad. Clínicamente presentaron dolor abdominal (45%), mareos (27%), pirosis (9%) y disfagia (1%). El 18% permaneció asintomático. Entre los signos encontrados figuran: melena (36%), pérdida de peso (27%), palidez cutánea (9%) y vómitos (9%). El 36% de los pacientes no presentaron hallazgos al examen físico. Se realizó ultrasonido abdominal en el 100% de los pacientes, con hallazgos patológicos relacionados con el tumor en el 27 % de los casos. Al 90% de los pacientes se les realizó una Endoscopia Digestiva Superior, el 82% de los hallazgos se describieron como Tumores Submucosos y 9% se reportó como normal. Las lesiones se ubicaron en el estómago (60%), 27% en el intestino delgado ( duodeno y yeyuno); 9% en esófago y 9% en retroperitoneo. El ultrasonido endoscópico fue practicado al 82% de los pacientes, con un porcentaje de aciertos diagnósticos en el 90% de los tumores localizados en esófago, estómago e intestino delgado, y de 87,5% si se incluye el tumor retroperitoneal. La Tomografía Computada (TC) de abdomen fue practicada en 45% de los pacientes, con hallazgos patológicos en el 100% de los casos, descritos como Lesiones Ocupantes de Espacio (LOE), en estómago, intestino, esófago y retroperitoneo; y en el 20% de los pacientes se encontró enfermedad metastásica hepática Recibieron tratamiento quirúrgico el 82%, el 18% restante no se realizó por contraindicación médica o se encuentran en espera del procedimiento. Y un 18% de los pacientes recibieron tratamiento médico con Imatinib...
We evaluated the clinical records with a diagnosis of mesenchymal tumors confirmed by immunohistochemical analysis, from 2007 to 2009. The objective was to describe the population according to clinical and epidemiological features, diagnostic imaging and histopathological analysis. We found 11 patients with diagnoses of GIST(7), leiomyoma(2), leiomyosarcoma(1) and GANT(1); (82%) female and (18%) male, with a mean age of 55 years. They clinically presented abdominal pain (45%), dizziness (27%), heartburn (9%) and dysphagia (1%). 18% remained asymptomatic. Among the symptoms were: melena (36%), weight loss (27%), paleness (9%) and vomiting (9%). 36% of the patients had no findings at physical examination. Abdominal ultrasound was performed in 100% of the patients, with pathological findings related to the tumor in 27% of cases. In 90% of patients an upper digestive endoscopy was performed. 82% of findings were described as submucosal tumors and 9% was reported as normal. Lesions were located in stomach (60%); 27% in small bowel (duodenum and jejunum), 9% in esophagus and 9% in retroperitoneum. Endoscopic ultrasound was performed to 82% of patients, with a diagnostic accuracy of 90% for the tumors located in esophagus, stomach and small bowel; and 87,5% if the retroperitoneal tumor is included. The abdomen Computed Tomography (CT) was performed in 45% of patients with pathological findings in 100% of the cases, described as Space occupying lesion (SOL) in stomach, intestine, esophagus and retroperitoneum; and, in 20% of patients metastatic liver cancer was found. 82% received surgical treatment, the remaining 18% was not performed due to contraindication or are waiting for the procedure. And 18% of patients received medical therapy with Imatinib...
Asunto(s)
Humanos , Masculino , Adulto , Femenino , Persona de Mediana Edad , Leiomioma/diagnóstico , Leiomioma/patología , Mesenquimoma/diagnóstico , Mesenquimoma/patología , Mesenquimoma/tratamiento farmacológico , Tumores Estromáticos Endometriales/complicaciones , Tumores Estromáticos Endometriales/diagnóstico , Tumores Estromáticos Endometriales/patología , Biopsia , Diagnóstico por Imagen , Endoscopía , Tracto Gastrointestinal/anatomía & histologíaRESUMEN
La displasia mesenquimal placentaria (DMP) es una anomalía vascular que presenta una baja incidencia (0,02%) y se caracteriza por una placentomegalia con múltiples vesículas en grano de uva en el examen ecográfico. El diagnóstico diferencial principal es la mola hidatiforme parcial, pero la DMP coexiste con feto viable. Se asocia a crecimiento intauterino restringido (CIR), muerte fetal y, en el 30% de los casos, síndrome de Beckwith-Wiedemann. El diagnóstico de sospecha de la DMP es ecográfico, pero el diagnóstico definitivo lo dará el estudio anatomopatológico. Presentamos 2 casos de DMP, cuyo diagnóstico no se realizó hasta el análisis histológico, que cursaron con resultados perinatales diferentes, así como una revisión bibliográfica de la displasia mesenquimal placentaria (AU)
Placental mesenchymal dysplasia (PMD) is a vascular abnormality with a very low incidence (0.02%) that is characterized by placentomegaly with multiple grapelike vesicles on ultrasound examination. The main differential diagnosis of PMD is partial hydatidiform mole. However, in contrast to a partial mole, PMD can coexist with a viable fetus. PMD is associated with fetal growth restriction, fetal demise and Beckwith-Wiedemann syndrome in 30% of cases. The suspected diagnosis is based on ultrasound examination, but the final diagnosis of PMD is made by histological analysis. We present two cases of PMD which were diagnosed at necroscopy and which had distinct outcomes. A literature review of placental mesenchymal dysplasia is also provided (AU)
Asunto(s)
Humanos , Femenino , Embarazo , Adulto , Enfermedades Placentarias/diagnóstico , Mesenquimoma/diagnóstico , Mola Hidatiforme/diagnóstico , Diagnóstico Diferencial , Síndrome de Beckwith-Wiedemann/diagnósticoRESUMEN
Tumor-induced osteomalacia (TIO) is a rare paraneoplasic syndrome with overproduction of fibroblast growth factor 23 as a phosphaturic agent, leading to chronic hyperphosphaturia and hypophosphatemia, associated with inappropriately normal or low levels of 1,25-dihydroxyvitamin D. Diagnosis of this disease is often challenging. The following case report described a middle-aged man with symptoms of bone pain and severe muscle weakness, who was found to have TIO. The tumor responsible for the symptoms was localized on his thigh and its resection resulted in normalization of blood chemistry and complaints. Subsequent microscopic examination revealed a phosphaturic mesenchymal tumor, mixed connective tissue type. The authors reinforce the importance of recognition of this disease, as severe disability and even death can be avoided with the surgical removal of the causative tumor.
Osteomalácia induzida por tumor (OIT) é uma síndrome paraneoplásica rara, causada por hiperprodução do agente fosfatúrico, levando a hipofosfatemia e hiperfosfatúria crônicas, associadas a níveis reduzidos ou inapropriadamente normais de 1,25-dihidroxivitamina D. O diagnóstico dessa doença é, geralmente, desafiador. O relato de caso aqui apresentado descreveu um homem de meia-idade, com quadro inicial de dor óssea, fraqueza muscular extrema e hipofosfatemia, com diagnóstico tardio de OIT. O tumor responsável pelos sintomas foi localizado em membro inferior, e sua exérese resultou em normalização das alterações bioquímicas e dos sintomas. O exame microscópico da lesão revelou tumor mesenquimal fosfatúrico, tecido conectivo misto. Os autores reforçam a importância do reconhecimento dessa entidade, uma vez que a remoção do tumor responsável pelos sintomas pode evitar sérias complicações ou mesmo a morte.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Hipofosfatemia/complicaciones , Mesenquimoma/complicaciones , Osteomalacia/etiología , Neoplasias de los Tejidos Blandos/complicaciones , Hipofosfatemia/diagnóstico , Mesenquimoma/diagnóstico , Mesenquimoma/cirugía , Osteomalacia/diagnóstico , Neoplasias de los Tejidos Blandos/diagnóstico , Neoplasias de los Tejidos Blandos/cirugíaRESUMEN
No disponible
Asunto(s)
Femenino , Lactante , Humanos , Mesenquimoma/diagnóstico , Neoplasias del Mediastino/diagnóstico , Lipoma/diagnóstico , Diagnóstico Diferencial , Neumonía/complicacionesRESUMEN
A chondrolipoma is an extremely rare form of a benign mesenchymal tumor containing mature cartilage and fatty tissue. Chondrolipomas may be found in almost any part of the body, particularly in the connective tissue of the breast, head and neck area, as well as in the skeletal muscle. However, to the best of our knowledge, chondrolipomas located in the pelvic cavity have not been reported. In this case report, we describe a case of a chondrolipoma in the pelvis, and show that it has its own characteristic imaging findings, which included the composition of fatty tissue and calcification in most parts, as well as some focal areas of chondroid tissue based on the CT and MR findings.
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Condroma/diagnóstico , Lipoma/diagnóstico , Mesenquimoma/diagnóstico , Neoplasias Pélvicas/diagnóstico , Tomografía Computarizada por Rayos XRESUMEN
Los tumores del estroma gastrointestinal forman un grupo infrecuente de neoplasias. Representan únicamente el 1-2 por ciento del total de tumores del tracto digestivo y la localización anorrectal es una de las menos descritas en la bibliografía. Se presenta un caso de tumor del estroma gastrointestinal situado en la parte distal del recto y el canal anal en un varón de 44 años de edad. Se revisan los datos clínicos y de tratamiento más significativos de este tipo de neoplasias (AU)
Asunto(s)
Adulto , Masculino , Humanos , Mesenquimoma/cirugía , Neoplasias del Ano/cirugía , Neoplasias del Recto/cirugía , Mesenquimoma/diagnóstico , Mesenquimoma/patología , Proteínas de Ciclo Celular , Procedimientos Quirúrgicos del Sistema Digestivo/métodos , Neoplasias del Ano/diagnóstico , Neoplasias del Ano/patología , Neoplasias del Recto/diagnóstico , Neoplasias del Recto/patología , Proteínas Proto-Oncogénicas c-kitRESUMEN
El blastoma adrenal es una neoplasia excepcional de la que hay una única publicación en un niño de 21 meses. Se presenta un caso similar desarrollado en un varón de 68 años. Se revisan los criterios anatomopatológicos e inmunohistoquímicos y el diagnóstico diferencial. En conclusión, el blastoma adrenal no es un tumor exclusivo de los niños (AU)
Asunto(s)
Anciano , Masculino , Humanos , Inmunohistoquímica/métodos , Fiebre/complicaciones , Fiebre/diagnóstico , Fiebre/etiología , Tomografía Computarizada de Emisión/métodos , Técnicas Histológicas , Mesenquimoma/cirugía , Mesenquimoma/complicaciones , Mesenquimoma/diagnóstico , Mesenquimoma/patología , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor , Biomarcadores de Tumor/administración & dosificación , Vimentina/análisis , Vimentina , Calcitonina , Cromograninas , Paraganglioma/complicaciones , Paraganglioma/diagnóstico , Paraganglioma/patología , Paraganglioma Extraadrenal/complicaciones , Paraganglioma Extraadrenal/diagnóstico , Paraganglioma Extraadrenal/etiología , Paraganglioma Extraadrenal/patología , Feocromocitoma/complicaciones , Feocromocitoma/diagnóstico , Feocromocitoma/patología , Corticoesteroides , Corticoesteroides/análisis , Neoplasias Renales/complicaciones , Neoplasias Renales/diagnóstico , Neoplasias Renales/cirugía , Neoplasias Renales/etiología , Neoplasias Peritoneales/cirugía , Neoplasias Peritoneales/diagnóstico , Neoplasias Peritoneales/etiología , Neoplasias Hepáticas/cirugía , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/etiología , Proteínas S100 , Neoplasias del Sistema Nervioso Periférico/diagnóstico , Neoplasias del Sistema Nervioso Periférico/complicaciones , Neoplasias del Sistema Nervioso Periférico/patología , Sistema Hipófiso-Suprarrenal/cirugía , Sistema Hipófiso-Suprarrenal/patología , Dolor de la Región Lumbar/diagnóstico , Dolor de la Región Lumbar/complicaciones , Dolor de la Región Lumbar/etiología , Histología Comparada/métodos , Adenoma Acidófilo/cirugía , Adenoma Acidófilo/diagnóstico , Adenoma Acidófilo/complicaciones , Adenoma Acidófilo/patología , Técnicas Citológicas , Diagnóstico Diferencial , Feocromocitoma/diagnóstico , Feocromocitoma/etiología , Feocromocitoma/fisiopatología , Blastoma Pulmonar/diagnóstico , Blastoma Pulmonar/patología , Blastoma Pulmonar/complicaciones , Blastoma Pulmonar/cirugíaRESUMEN
Los tumores del mesénquima de la vulva son poco frecuentes. Por otra parte, el angiomixoma de comportamiento clínico agresivo es una lesión recientemente caracterizada que se presenta principalmente en los tejidos blandos de la pelvis y tiene tendencia a recurrir localmente. Las variedades benignas suelen ser de dimensiones menores y generalmente se confunden con quistes de la glándula de Bartholin. En este trabajo se describe el caso de un tumor mesenquimatoso mixto gigante y benigno de la vulva con características clínicas atípicas
Asunto(s)
Humanos , Femenino , Adolescente , Mesenquimoma/diagnóstico , Mesenquimoma/cirugía , Mesenquimoma/ultraestructura , Neoplasias de la Vulva/diagnóstico , Neoplasias de la Vulva/cirugía , Neoplasias de la Vulva/ultraestructuraRESUMEN
Os autores apresentam um caso raro de mesenquimoma benigno de cápsula renal em um homem de 43 anos, sem sintomatologia clínica significativa. Descrevem as características macroscópicas e histológicas e fazem uma revisäo da literatura